Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the safety and efficacy of a reduced
intensity conditioning regimen during a double umbilical cord blood unit transplant with one
of the cord blood units modulated with ProHema.